San Diego, USA-based Neurocrine Biosciences announced that its Phase III KINECT-DCP study evaluating the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback